How Does Kratom Affect Depression? Effects, Risks & Research

Quick Answer: Kratom interacts with opioid, serotonin, and dopamine receptors in ways that may temporarily lift mood and reduce depressive symptoms. However, clinical research on kratom for depression is thin, no FDA-approved indication exists, and dependence risk is real. It is not a replacement for proven antidepressant therapy.

What Is Kratom and How Does It Work in the Body

Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia. Its leaves contain over 40 alkaloids, but two drive most of its pharmacological effects: mitragynine and 7-hydroxymitragynine.

The mechanism works like this. Mitragynine binds to mu-opioid receptors but behaves as a partial agonist, not a full agonist like morphine. That partial binding is why kratom produces mood elevation and pain relief without the same degree of respiratory depression that opioids cause at equivalent doses. At the same time, mitragynine also hits adrenergic and serotonin receptors, which matters directly for mood regulation.

At low doses (1-5 g), kratom acts more like a stimulant. Receptors respond with increased energy, focus, and mild euphoria. At higher doses (5-15 g), the opioid-like sedation dominates. This dose-dependent switch is pharmacologically important and explains why user experiences vary so widely.

For a deeper look at how long these effects persist in the body, see how long kratom effects last.

Can Kratom Help With Depression Symptoms

Kratom may temporarily relieve some depression symptoms by activating mood-related receptor pathways. Whether that constitutes “treating” depression is a different question entirely.

The serotonin and dopamine activity from mitragynine can produce short-term mood elevation. Users frequently report reduced sadness, increased motivation, and a sense of calm. A 2020 Johns Hopkins survey (n=2,798) found that 67% of respondents used kratom for mood-related reasons, and many reported it more effective than prescription medications for their symptoms. That sounds compelling until you read the methodology: it was an online self-selected survey. Study limitations here are significant.

What the science does not yet show is whether kratom produces sustained antidepressant effects, whether it addresses the underlying neurochemical deficits in clinical depression, or whether benefits outlast the acute dosing window. The honest answer is: we do not know.

What Does the Research Say About Kratom for Mental Health

The research base is genuinely thin. There are no randomized controlled trials on kratom for depression as of 2026.

Study	Year	Sample	Finding	Limitation
Johns Hopkins survey	2020	2,798	Mood/anxiety improvement reported	Self-report, no control group
Swogger & Walsh review	2015	Literature review	Mood lift, anxiolytic effects noted	No clinical trials cited
NIDA-funded animal studies	Various	Rodent models	Mitragynine shows antidepressant-like effects	Animal data, not human trials
Boyer et al. case series	2008	8 cases	Dependence and withdrawal documented	Small, clinical cases only

According to research published in the Journal of Psychoactive Drugs (2017), mitragynine demonstrated antidepressant-like activity in rodent forced-swim tests, a standard preclinical screen. But animal models of depression are notoriously poor predictors of human outcomes.

The National Institute on Drug Abuse (NIDA) acknowledges that kratom affects brain chemistry in ways relevant to mood but classifies the evidence base as insufficient to support therapeutic claims. Research gaps here are wide. Until controlled human trials exist, any claim that kratom “treats” depression is ahead of the data.

Is Kratom Safe to Take With Antidepressants

No, combining kratom with most antidepressants is not considered safe. This is one of the clearest risk signals in the available safety data.

The specific dangers:

• SSRIs + Kratom: Both affect serotonin pathways. Combining them raises serotonin syndrome risk, a potentially life-threatening condition involving agitation, rapid heart rate, and hyperthermia.
• MAOIs + Kratom: This combination is especially dangerous. MAOIs inhibit the enzyme that breaks down mitragynine’s metabolites, dramatically increasing plasma levels and toxicity risk.
• TCAs + Kratom: Both have cardiac effects. Combined use may increase arrhythmia risk.
• Kratom also inhibits CYP3A4 and CYP2D6 liver enzymes, which metabolize many antidepressants. This can raise drug levels unpredictably.

Anyone currently taking prescription antidepressants should consult a physician before considering kratom. Full stop.

What Are the Side Effects of Kratom

Kratom’s side effects range from mild and dose-dependent to serious and potentially life-threatening with heavy use.

Common side effects:

• Nausea and vomiting (especially at higher doses)
• Constipation
• Dizziness and sedation
• Dry mouth
• Increased urination

Serious side effects (documented in case reports):

• Liver toxicity (hepatotoxicity), multiple case reports exist
• Seizures, particularly with high doses or poly-drug use
• Psychosis in rare cases
• Respiratory depression when combined with other CNS depressants

The FDA has linked kratom to over 40 deaths, though most involved poly-substance use. The agency maintains an active import alert on kratom products. According to the FDA’s 2019 safety communication, kratom has properties that expose users to risks of addiction, abuse, and dependence.

How Much Kratom Should I Take for Depression

There is no clinically established dose for depression because no clinical trials have established one. What exists is community-reported dosing, which varies considerably.

General dose ranges reported by users:

• Low (1-3 g): Stimulant-like effects, mild mood lift, increased focus
• Moderate (3-6 g): More pronounced euphoria, anxiolytic effects, sedation beginning
• High (6-12 g+): Heavy sedation, opioid-like effects, higher risk of nausea and adverse events

For detailed guidance on dosing variables, see how much kratom to take.

The practical advice here: start low, go slow, and do not increase dose chasing a mood effect. Tolerance builds quickly with kratom, and escalating doses are the primary driver of dependence.

Kratom vs Antidepressants: Which Is Better

Antidepressants have decades of clinical trial data behind them. Kratom does not. For treating clinical depression, antidepressants are the evidence-based choice.

That said, the comparison is not entirely one-sided. SSRIs take 4-8 weeks to reach therapeutic effect and carry their own side effect profiles, including sexual dysfunction, weight gain, and discontinuation syndrome. Some users turn to kratom precisely because they found antidepressants ineffective or intolerable.

The honest comparison:

• Antidepressants: Proven efficacy in RCTs, regulated dosing, FDA oversight, known safety profile, slow onset
• Kratom: Rapid mood effect, unregulated, no clinical trial data, dependence risk, variable potency by batch

Choose antidepressants if you have a clinical depression diagnosis. Kratom is not a medically validated substitute.

Can Kratom Cause Addiction or Dependence

Yes. Kratom causes physical dependence with regular use, and withdrawal is documented and uncomfortable.

Because mitragynine activates mu-opioid receptors, the brain adapts to its presence. Stop using it, and the receptors rebound. Withdrawal symptoms typically appear within 12-24 hours of the last dose and include muscle aches, insomnia, irritability, nausea, anxiety, and depression, the very symptom users were trying to relieve.

The American Kratom Association (AKA) acknowledges dependence risk and advocates for responsible use guidelines. NIDA classifies kratom as a drug of concern with abuse potential. For a realistic picture of what withdrawal involves, see how long kratom withdrawal lasts.

What Kratom Strains Are Best for Mood and Anxiety

Green and white vein kratom strains are most commonly reported for mood elevation. Red vein strains lean more sedating.

Strains frequently mentioned for mood:

• Green Maeng Da: Balanced stimulation and mood lift. See green Maeng Da kratom for energy and focus.
• White Maeng Da: More stimulating, reported for motivation and focus. Details at White Maeng Da kratom effects.
• Gold Vietnam: Often described as mood-balancing with moderate energy. See Gold Vietnam kratom effects.
• Green Elephant: Reported for calm focus and mild euphoria. More at Green Elephant kratom effects.

The science here is clear: strain names are not standardized, and alkaloid content varies by harvest, region, and vendor. What one vendor calls “Green Maeng Da” may differ significantly from another’s. Treat strain claims as rough guides, not precise pharmacological categories.

Is Kratom Legal and Regulated by the FDA

Kratom is federally legal in the United States as of 2026, but it is not FDA-approved for any use. The FDA has actively tried to restrict it and classifies it as a “botanical drug” of concern.

At the state level, kratom is banned in Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin. Several other states have age restrictions or pending legislation. For a current state-by-state breakdown, see the kratom legal states updated list.

The DEA considered scheduling kratom as a Schedule I substance in 2016 but withdrew the proposal after significant public pushback. It remains on the DEA’s “drugs of concern” list. The lack of FDA regulation means product quality, potency, and purity are not guaranteed.

How Long Does It Take Kratom to Work for Depression

Kratom typically begins producing effects within 15-30 minutes of oral ingestion. Peak effects occur around 60-90 minutes in. For a detailed breakdown of onset timing, see how long kratom takes to kick in.

This rapid onset is pharmacologically different from antidepressants, which require weeks of consistent dosing to build therapeutic effect. Kratom’s quick action is part of its appeal, and part of its risk. Fast-acting mood relief reinforces repeated use, which accelerates tolerance and dependence development.

What Are the Risks of Using Kratom Long Term

Long-term daily kratom use carries compounding risks that go beyond acute side effects.

Documented long-term risks:

• Physical dependence and withdrawal syndrome
• Liver damage (hepatotoxicity), case reports document cholestatic hepatitis
• Cognitive effects including memory and concentration issues
• Hormonal disruption, particularly testosterone suppression (limited data)
• Psychological dependence and mood instability between doses

Research gaps are significant here. No long-term prospective studies exist. Most data comes from case reports and cross-sectional surveys. The absence of data does not mean safety, it means we do not yet know the full picture.

Who Should Not Use Kratom for Mental Health

Several groups face elevated risk and should avoid kratom entirely.

• People with a history of substance use disorder: Opioid receptor activity makes kratom particularly habit-forming for this population.
• Pregnant or breastfeeding women: Neonatal abstinence syndrome has been reported in infants born to kratom-using mothers.
• People with liver disease: Hepatotoxicity risk is higher in those with compromised liver function.
• People taking antidepressants, opioids, or benzodiazepines: Drug interaction risk is serious (see the antidepressant section above).
• People with bipolar disorder or psychosis history: Kratom’s stimulant effects at low doses may trigger manic or psychotic episodes.
• Adolescents and young adults: Developing brains are more vulnerable to opioid receptor modulation.

Frequently Asked Questions

---

Does kratom actually work for depression?

Some users report changes in mood after using kratom, but there is not enough clinical evidence to establish kratom as an effective treatment for depression. Regular use may also carry dependence and withdrawal risks.

How is kratom different from antidepressants?

Antidepressants are prescription medicines studied in clinical trials and may take weeks to produce their full effects. Kratom acts on several brain receptors, including opioid receptors, but it has not been approved as a treatment for depression.

Can kratom make depression worse?

Some people report worsening mood between uses or after regular kratom use. Tolerance, dependence, withdrawal, and changes in use patterns may affect mood, but individual experiences vary.

What is the safest way to try kratom for mood?

There is no medically established safe dose of kratom for treating mood disorders. If someone is considering kratom, they should discuss the risks with a healthcare professional and avoid combining it with other substances.

Is kratom addictive like opioids?

Kratom interacts with opioid receptors and regular use can lead to tolerance, dependence, and withdrawal. Its effects differ from those of traditional opioids, but dependence can still occur with repeated use.

How long does kratom stay in your system?

Mitragynine can remain in the body after its noticeable effects wear off, and its elimination varies between individuals. Metabolites may persist longer. See how long kratom stays in your system for more information.

Does the FDA approve of kratom for depression?

No. Kratom is not FDA-approved for treating depression or any other medical condition. The FDA has also raised safety concerns regarding kratom products and their potential risks.

Can you buy kratom legally?

Kratom’s legal status varies by location. Some U.S. states and local jurisdictions restrict or prohibit it, while others allow sales under certain conditions. Check current local laws before purchasing or possessing kratom.

What dose of kratom is dangerous?

There is no universally established toxic threshold for kratom. Risk can increase with larger amounts and combinations with other substances, and serious adverse events have been reported. A specific amount should not be assumed to be safe for everyone.

Are some kratom strains better for anxiety than depression?

Users often describe different effects from green, white, and red vein products, but these strain-based differences have not been clinically established for treating anxiety or depression. Individual responses can also vary.

Conclusion

The question of how kratom affects depression comes down to this: the pharmacology is real, the clinical evidence is not. Mitragynine hits the right receptors to produce mood-relevant effects, and many users report genuine relief. But no controlled trials confirm efficacy, safety data is incomplete, and dependence risk is documented and serious.

The science here is still developing. Stay skeptical of both the miracle-cure claims and the blanket condemnations. What we know is useful. What we do not yet know is substantial.

References

• Swogger, M.T., & Walsh, Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 183, 134-140.
• Garcia-Romeu, A., et al. (2020). Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence, 208. Johns Hopkins Medicine.
• Boyer, E.W., et al. (2008). Self-treatment of opioid withdrawal using kratom. American Journal on Addictions, 17(5), 114-116.
• U.S. Food and Drug Administration. (2019). FDA and Kratom. https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
• National Institute on Drug Abuse. (2022). Kratom DrugFacts. https://nida.nih.gov/publications/drugfacts/kratom
• Prozialeck, W.C., et al. (2012). Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association, 112(12), 792-799.